The osteoclasts are bone-resorbing multinucleated cells formed by the fusion of mononuclear preosteoclasts (pOCs) of hematopoietic origin. Although receptor activator of NF-κB ligand (RANKL) has been shown to regulate osteoclast differentiation and function, its effect on the fusion of pOCs into multinucleated osteoclast-like cells (OCLs) has not been known. Using our fusion assay system, that is not contaminated with multinucleated cells (MNCs) and osteoblastic cells, we determined the effect of RANKL on the fusion of pOCs into MNCs. When pOCs were cultured on the plates, most of pOCs died and disappeared from the plates within 24 h in the absence of additives, but pOCs were fused to MNCs within 6 h in the presence of RANKL. RANKL-induced MNCs showed typical properties of OCL such as tartrate-resistant acid phosphatase (TRAP) activity, actin ring formation, and bone-resorbing activity. The fusion of pOCs into OCLs induced by osteoblastic cells or RANKL was inhibited by OPG/OCIF, but that induced by IL-1β was not. Both RANKL-and IL-1β-induced OCL formation from pOCs was inhibited by ZLLL-H, a peptide inhibitor of proteasome. These findings indicate that RANKL supports the survival of pOCs and induces the fusion of pOCs into OCLs and suggest that NF-κB activation is involved in these processes induced by RANKL and IL-1β.
Introduction
Osteoclasts are bone-resorbing multinucleated cells (having between 2 to 100 nuclei per cell) that play a critical role in bone remodeling. They are formed by the fusion of mononuclear preosteoclasts (pOCs), that are differentiated from hematopoietic precursors (Athanasou, 1996; Roodman, 1996; Suda et al., 1996) . Osteoclasts are activated to have boneresorbing activity (Jimi et al., 1999; Wesolowski et al., 1995) . It has been shown that osteoblastic/stromal cells are essential for osteoclast differentiation and activation (Suda et al., , 1996 . To study the mechanism of osteoclast differentiation and function, a co-culture system of mouse bone marrow cells and osteoblastic/stromal cells has been used (Roodman, 1996; Suda et al., 1996) . Multinucleated osteoclastlike cells (OCLs) have been known to be formed in the cultures containing osteoclast-inducing factors such as 1α, 25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ], para-thyroid hormone and interleukin 11 (IL-11) (Takahashi et al., 1988) . Due to the difficulty of isolating the pOCs without contamination of MNCs and osteoblastic cells, the mechanism of the fusion of pOCs has hardly been known. We have established a procedure to isolate pOCs without contamination with MNCs and osteoblastic cells from co-cultures of mouse osteoblastic cells and bone morrow cells in the presence of 1,25(OH) 2 D 3 (Takami et al., 1998) . Using the isolated pOCs, we have developed a fusion assay system and reported that osteoblasts are essential for the fusion of pOCs into OCLs (Takami et al., 1998) .
Receptor activator of NF-κB ligand (RANKL, Wong et al., 1997a, b) , also called TNF-related activation induced cytokine (TRANCE, Anderson et al., 1997) , osteoclast differentiation factor (ODF, Yasuda et al., 1998) , osteoprotegerin ligand (OPGL, Lacey et al., 1998) , has been identified as a novel member of the TNF superfamily that regulates immune responses and bone resorption. RANKL, expressed in T cells, has been reported to support the survival of dendritic cells (Wong et al., 1997a, b) . Furthermore, RANKL expressed in bone marrow stromal or osteoblastic cells that are stimulated with bone-resorbing factors such as PTH, 1,25(OH) 2 D 3 , IL-11 and PGE 2 , has been shown to induce osteoclasts differentiation from their progenitors in the presence of M-CSF in the absence of stromal or osteoblastic cells and to stimulate osteoclastic bone resorption Lacey et al., 1998) . It was demonstrated that RANKL-induced osteoclast formation is inhibited by osteoprotegerin (OPG; also called OCIF), which is a soluble member of the TNFR superfamily Lacey et al., 1998) . Recently, RANK, which is a member of the TNF receptor superfamily that activates NF-κB, has been reported to be an essential signaling receptor for osteoclast differentiation induced by RANKL Hsu et al., 1999) . IL-1β is known to promote the survival of mature osteoclasts through IL-1 type I receptors by stimulating NF-κB activation (Jimi et al., 1995 (Jimi et al., , 1998 Suda et al., 1997) . Recently, IL-1β has been reported to induce multinucleation of osteoclasts in the absence of osteoblastic/stromal cells (Jimi et al., 1999) . The effect of RANKL on the survival of pOCs and the fusion of pOCs into OCLs has not been determined, although it was revealed that RANKL clearly induces osteoclast differentiation and stimulates the function of mature osteoclasts.
The object of this study is to examine the effect of RANKL on the survival of pOCs and the fusion of pOCs into MNCs. We show here that IL-1β or RANKL supports the survival of pOCs and then induces the fusion of pOCs into OCLs, that the fusion of pOCs induced by RANKL is inhibited by OCIF/OPG, but the fusion of those induced by IL-1β is not, and that both RANKL-and IL-1β-induced fusion of pOCs are blocked by ZLLL-H, a proteasome inhibitor. 
Materials and methods

Animals and chemicals
Five-to eight-week-old male mice and newborn mice of ddY strain were obtained from Sankyo Labo Service Co.. Chemicals such as sodium tartrate, Fast Red Violet LB Salt, Mayer's hematoxylin and Naphthol AS-MX Phosphate were purchased from Sigma Chemical Co.. Recombinant human RANKL and recombinant murine IL-1β were purchased from Pepro Tech EC Ltd. (London, England) and R&D Systems (Minneapolis, MN). Collagenase, dispase and collagen gel solution were purchased from Wako Pure Chemical Industries Ltd. (Osaka, Japan), Godo Shusei and Nitta Gelatin Co., respectively. Fetal calf serum was obtained from CSL Ltd. ZLLL-H was purchased from Peptide Institute Inc (Osaka, Japan). OPG was a generous gift from Dr. Kwon (Indiana University School of Medicine).
Preparation of pOCs
Bone marrow cells were collected from femora and tibiae of five-to eight-week-old male mice as described (Takahashi et al., 1988) . Primary osteoblastic cells were prepared from calvaria collected from newborn mice. A total of 40 to 50 calvaria were subjected to five sequential digestions using 0.1% collagenase and 0.2% dispase as described. Mouse osteoblastic cells (2 × 10 6 cells/dish) were cocultured with bone marrow cells (2 × 10 7 cells/dish) in α-MEM containing 10% fetal calf serum and 10 −8 M 1,25(OH) 2 D 3 in 100 mm culture dish. All cultures were maintained at 37 • C in a humidified atmosphere of 5% CO 2 in air. After culturing for 5 days, floating cells were removed and cells attached on osteoblastic cell layers were recovered as pOCs by pipetting with fresh α-MEM. Prepared pOCs were fixed and stained for TRAP, a marker enzyme of osteoclasts, and TRAPpositive mononuclear cells were counted as pOCs. This preparation of pOCs was not contaminated with MNCs or osteoblastic cells, and composed of more than 50-60% of TRAP-positive mononuclear cells without osteoblastic cells and MNCs.
Fusion assay system pOCs (1 × 10 5 cells/well) were cultured in each well of 96 well tissue culture plates (100 µl/well) in the presence or absence of osteoblastic cells, RANKL or IL-1β. After culturing for 24 h, cells were fixed and stained for TRAP. The number of TRAP-positive MNCs with more than 4 nuclei was counted.
Pit formation assay
pOCs (1 × 10 5 cells/well) were placed on dentine slices (4 mm diameter) in the presence or absence of osteoblastic cells, RANKL and IL-1β in each well of 96-well plates containing 0.2 ml α-MEM supplemented with 10% FCS. After incubation for 48 h, cells were removed with the treatment of 0.05 M NH 4 OH for 30 min from dentine slices and resorption pits were stained with Mayer's hematoxylin as described in Nakamura et al. (1995) .
Results
We have previously reported that osteoblastic cells are essential for the fusion of pOCs into OCLs (Takami et al., 1998) . Since RANKL induces osteoclast differentiation from their precursor cells in the presence of M-CSF without osteoblastic or stromal cells Lacey et al., 1998) , we determined whether RANKL induces the fusion of pOCs into OCLs in the absence of osteoblastic cells. When pOCs were cultured without any additives on plates, they survived for 2 h. Their survival allowed the spontaneous fusion of pOCs into MNCs having more than 3 nuclei Figure 5 . Effect of OPG on MNC formation induced by RANKL or IL-1β. pOCs (1 × 10 5 cells/100 µl/well) were cultured with OPG (1000 ng ml −1 ) in 96-well plates in the presence of RANKL (100 ng ml −1 ) and IL-1β (10 ng ml −1 ) for 24 h. Cells were then fixed and stained for TRAP. TRAP-positive MNCs having more than 3 nuclei were counted as OCLs. Data are expressed as the mean ± SD of 3 cultures.
( Figures 1A and 2E ), but most of the TRAP-positive pOCs and MNCs died within 24 h and disappeared from the plates ( Figures 1A, B and Figures 2F, G) . However, when pOCs were cultured with RANKL for 24 h, TRAP-positive pOCs survived, and consequently the pOCs fused to form MNCs (Figures 2B-D) . The number of MNCs was increased during the culture for 24 h ( Figure 1A) . After 12 h both TRAP-positive and MNCs having more than 4 nuclei were retained on the plates in the presence of RANKL. The decrease of the number of pOCs in the presence of RANKL, shown in Figure 2B , is considered to be due to multinucleation of pOCs as a consequence of fusion. To compare the effect of RANKL with that of IL-1β, the effect of IL-1β on the fusion of pOCs into MNCs was determined. IL-1β, also supported the survival of pOCs and induced the fusion of pOCs into MNCs ( Figure 3C ). The effect of RANKL on the multinucleation of pOCs (having more than 4 nuclei) was dose-dependent in the concentration range of 10-100 ng ml −1 (Figure 4) . The potency of RANKL on the fusion was comparable to that on osteoclast differentiation from hematopoietic precursor cells without osteoblastic/stromal cells. Next, it was examined whether MNCs induced by RANKL from pOCs have osteoclastic features. Figures 3A-C) and actin ring formation, as detected by staining Factin with rhodamine-conjugated phalloidin (data not shown). pOCs were cultured on the dentine slices to determine the bone-resorbing activity of OCLs induced by RANKL. In the absence of additives no resorption pit was detected ( Figure 3H ). When pOCs were cultured for 48 h in the presence of RANKL, many resorption pits were formed on dentine slices similar to these cultured in the presence of IL-1β or osteoblastic cells (Figures 3E-G) . Thus, RANKLinduced MNCs are considered to be OCLs, like IL-1β-or osteoblastic cell-induced osteoclasts.
RANKL-induced OCLs showed typical properties of osteoclast in terms of TRAP activity (
Since RANKL-induced osteoclast differentiation is inhibited by OPG/OCIF, a decoy receptor of RANKL Lacey et al., 1998) , we examined the effect of OPG/OCIF on the fusion of pOCs induced by osteoblastic cells, IL-1β or RANKL. Multinucleation of pOCs induced by osteoblastic cells or RANKL was inhibited by OPG, but that induced by IL-1β was not ( Figure 5 ). When pOCs were treated with 1000 ng ml −1 OCIF in the presence of RANKL, neither TRAP-positive pOCs nor OCLs were retained on the plates (data not shown). RANKL is shown to Figure 6 . Effect of ZLLL-H on the fusion of pOCs induced by RANKL (100 ng ml −1 ) or IL-1β. pOCs (1 × 10 5 cells/100 µl/well) were cultured with ZLLL-H (10 µg ml −1 ) in 96-well plates in the presence of RANKL (100 ng ml −1 ) and IL-1β (10 ng ml −1 ) for 24 h. Cells were then fixed and stained for TRAP. TRAP-positive MNCs having more than 4 nuclei were counted as OCLs. Data are expressed as the mean ± SD of 3 cultures.
be a ligand of RANK that activates NF-κB Darnay et al., 1998; Nakagawa et al., 1998) , and IL-1β also promotes the survival of mature osteoclasts by activating NF-κB through IL-1β type I receptors (Jimi et al., 1998) . Thus, a peptide inhibitor of proteasome ZLLL-H, which inhibits NF-κB activation by blocking proteasome activity participating in the degradation of IκB of NF-κB/IκB complex, was used to investigate whether NF-κB-signaling pathway is involved in the process of fusion of pOCs induced by these two cytokines. When pOCs were treated with ZLLL-H in the presence of RANKL or IL-1β the formation of OCLs having more than 4 nuclei were inhibited (Figure 6 ). The number of pOCs were also decreased in the presence of ZLLL-H (data not shown).
Discussion
Osteoblastic/stromal cells play a critical role in the differentiation and activation of osteoclast through a cell-to-cell interaction (Fuller et al., 1998; Suda et al., 1997 Suda et al., , 1995 . RANKL is expressed as a membranebound type protein in stromal/osteoblastic cells that support osteoclast differentiation and activate mature osteoclast to resorb bone Lacey et al., 1998) . These RANKL effects on the differentiation and activation of osteoclasts are inhibited by OPG/OCIF, a decoy receptor of RANKL , Simonet et al., 1997 . It has been shown that stromal cells are involved in osteoclast survival (Jimi et al., 1995) . Recently, OPG/OCIF was also reported to inhibit osteoclast survival and induce apoptosis in the presence of stromal cells (Akatsu et al., 1998) . It is indicated that OPG/OCIF inhibits osteoclast formation, activation and survival by disrupting the interaction between RANKL on the stromal cells and its receptor on osteoclast progenitors or mature osteoclasts Lacey et al., 1998; Akatsu et al., 1998) . We previously reported that osteoblastic cells are also essential for the survival of pOCs and the fusion of pOCs into OCLs (Takami et al., 1998) . In this study we showed that RANKL promotes the survival of pOCs, and then induces the fusion of pOCs into OCLs in the absence of M-CSF without the help of osteoblastic/stromal cells. MNCs formed from pOCs in the presence of RANKL showed typical osteoclast properties with TRAP activity, actin ring formation and bone-resorbing activity. The survival and fusion of pOCs induced by RANKL as well as osteoblastic cells were inhibited by OPG/OCIF, suggesting that OPG functions as a decoy receptor of RANKL to interfere the binding of RANKL to its receptors expressed on pOCs. These findings indicate that RANKL could substitutes for the role of osteoblastic/stromal cells in the survival of pOCs and the fusion of pOCs into OCLs.
Activation of the NF-κB family of transcriptional factors are known to regulate the expression of genes that participate in the pathways involving cell proliferation and apoptosis (Baldwin, 1996) . The activation of NF-κB is also an important process for survival of mature osteoclast (Jimi et al., 1995) . Recently, RANK, which is known to have the capacity of activating NF-κB, has been shown to be an essential signaling receptor for osteoclast differentiation from their progenitors . RANKL-mediated osteoclastogenesis can be induced by the activation of NF-κB through RANK in progenitors . IL-1β also promotes the survival of mature osteoclasts by activating NF-κB through IL-1β type I receptors and induces the fusion of pOCs into OCLs (Jimi et al., 1998 (Jimi et al., , 1999 . A common feature of NF-κB regulation is their sequestration in the cytoplasm as an inactive complex with IκB to keep the molecule from being translocated into the nucleus (Siebenlist et al., 1995) . It is known that degradation of IκB by proteasome is a prerequisite for NF-κB activation (Siebenlist et al., 1995) . An experiment using ZLLL-H has revealed that IL-1β -induced survival of purified mature osteoclasts is due to a result of activation of NF-κB through the degradation of IκB (Jimi et al., 1998) . In the present study ZLLL-H inhibited the fusion of pOCs into OCLs induced by RANKL or IL-1β. It is thought that the effect of ZLLL-H is resulted from the decrease of the number of pOCs survived. OPG/OCIF also inhibited the fusion of pOCs induced by osteoblastic cells or RANKL in a similar manner. When pOCs were cultured without RANKL or IL-1β, TRAP-positive pOCs also died by apoptosis (our unpublished data) and then no OCLs were formed. Thus, inhibitory effect of ZLLL-H on the fusion of pOCs, like that of OPG/OCIF, is considered to be a consequence of pOC apoptosis caused by blocking the activation of NF-κB for survival signaling. These facts suggest that NF-κB activation is an important process for the survival and the fusion of pOCs induced by RANKL or IL-1β.
Although the effect of RANKL on the fusion of pOCs into OCLs and on the activation of OCLs is similar to that of IL-1β (Suda et al., 1997; Fuller et al., 1998) , IL-1β could not substitute for the effect of RANKL on the early stage, the differentiation of progenitor cells into preosteoclasts. Several members of TNF receptor superfamily interact with signaling adapter proteins (TNF receptor-associated factors, TRAFs) to activate NF-κB (Rothe et al., 1994) . TRAF2, TRAF5 and TRAF6 of TRAF molecules have been demonstrated to mediate signaling of NF-κB (Malinin et al., 1997; Song et al., 1997; Regnier et al., 1997; Mercurio et al., 1997; Woronicz et al., 1997) . Recently, Darnay et al. (1998) and Wong et al. (1998) have independently reported that distinct intracellular region of RANK associates with TRAF2, TRAF5 and TRAF6 to initiate NF-κB activation. RANKL may play a critical role in the polyfunctions of dendritic cells and osteoclasts through the RANK by activating NF-κB via these three TRAFs. It should be studied which TRAFs are involved in the signaling pathway of RANKL and IL-1β, and if the difference between RANKL and IL-1β activity is attributed to the difference of TRAFs involved.
In summary, we found that RANKL induces the survival of pOCs and fusion of pOCs into OCLs, that osteoblastic cell-or RANKL-induced fusion of pOCs are inhibited by OPG/OCIF and that IL-1β-or RANKL-induced fusion of pOCs are inhibited by peptide inhibitor of proteasome. These findings suggest that NF-κB activation is an important process for the survival and fusion of pOCs induced by osteoblastic/stromal cells. It was also suggested that NF-κB activation by RANKL is an essential signaling pathway for all steps in osteoclastogenesis, the differentiation of progenitors into pOCs, the survival of pOCs, the fusion of pOCs into OCLs, and the activation of mature osteoclasts.
